A view of University of Oklahoma Health Sciences Center campus on Sept. 5, 2024. (Photo by Janelle Stecklein/Oklahoma Voice)
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer.
The trial was led by the University of Texas MD Anderson Cancer Center, enrolling 440 patients across 21 institutions…